Anaplastic Oligodendroglioma (AO) Terminated Phase 2 Trials for Talampanel (DB04982)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00062504Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasTreatment